Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline plus standard treatment for outpatient COVID-19
IRCT20191211045691N2Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Doxycycline plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoints: Improvement in fever, Improvement in cough and 1 more. Started Sep 2020; status: completed.
02
Drugs
doxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20191211045691N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191211045691N2.